US Congress Subject | Prescription drugs

Filter View [Reset All]
Syndicate content
StanceStateBillStatusSummary/TitleLast Actionsort icon
USSB2938PassDesignates (1) the Federal Building and United States Courthouse located at 111 North Adams Street in Tallahassee, Florida, as the Joseph Woodrow Hatchett United States Courthouse and Federal Building; and (2) the U.S. Postal Service facility located...
[Detail][Text][Discuss]
2022-06-25
Became Public Law No: 117-159.
USSB4348Intro
25%
A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.
[Detail][Text][Discuss]
2022-06-14
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
USHB7667Engross
50%
Reauthorizes Food and Drug Administration (FDA) user fee programs for certain drugs and devices, establishes requirements to increase diversity in clinical trials, and modifies requirements relating to the overall supply chain for drugs and devices. ...
[Detail][Text][Discuss]
2022-06-09
Received in the Senate.
USHB6833Engross
50%
Limits cost-sharing for insulin under private health insurance and the Medicare prescription drug benefit. Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $35 or 25% of a pl...
[Detail][Text][Discuss]
2022-05-25
Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 389.
USSB4282Intro
25%
Provides support for restaurants and other businesses impacted by the COVID-19 pandemic and extends the moratorium on the implementation of a Department of Health and Human Services rule related to prescription drug pricing. Specifically, the bill pr...
[Detail][Text][Discuss]
2022-05-19
To Senate Small Business And Entrepreneurship Committee
USSB4204Intro
25%
Establishes a national health insurance program that is administered by the Department of Health and Human Services (HHS). Among other requirements, the program must (1) cover all U.S. residents; (2) provide for automatic enrollment of individuals up...
[Detail][Text][Discuss]
2022-05-12
To Senate Finance Committee
USSB4132Intro
25%
Prohibits governmental restrictions on the provision of, and access to, abortion services. Specifically, governments may not limit a provider's ability to prescribe certain drugs, offer abortion services via telemedicine, or immediately provide abort...
[Detail][Text][Discuss]
2022-05-11
Cloture on the motion to proceed to the measure not invoked in Senate by Yea-Nay Vote. 49 - 51. Record Vote Number: 170. (CR S2439)
USHB7573Intro
25%
Expands and otherwise modifies coverage of telehealth services under Medicare until two years after the end of the COVID-19 public health emergency. Specifically, the bill (1) allows federally qualified health centers and rural health clinics to serv...
[Detail][Text][Discuss]
2022-04-26
To House Energy And Commerce Committee
USHB7400Intro
25%
To direct the Secretary of Health and Human Services to conduct a demonstration program to test providing preferential treatment under the Medicare, Medicaid, and CHIP programs for certain drugs and biologicals manufactured in the United States.
[Detail][Text][Discuss]
2022-04-05
To House Energy And Commerce Committee
USSB3991Intro
25%
A bill to direct the Secretary of Health and Human Services to conduct a demonstration program to test providing preferential treatment under the Medicare, Medicaid, and CHIP programs for certain drugs and biologicals manufactured in the United State...
[Detail][Text][Discuss]
2022-04-05
To Senate Finance Committee
USHB7410Intro
25%
Allows employers tax credits for domestic medical and drug manufacturing expenses and for advanced medical manufacturing equipment. It also provides a tax credit for a percentage of the basis of qualifying medical manufacturing EPA compliance propert...
[Detail][Text][Discuss]
2022-04-05
To House Ways And Means Committee
USHB7121Intro
25%
To require the Secretary of Health and Human Services to maintain a list of the country of origin of all drugs marketed in the United States, to ban the use of Federal funds for the purchase of drugs manufactured in the People's Republic of China, an...
[Detail][Text][Discuss]
2022-03-28
To House Subcommittee on Health
USSB3842Intro
25%
A bill to amend title VI of the Social Security Act to permit State and local coronavirus fiscal recovery funds to be used to address increased costs of essential items.
[Detail][Text][Discuss]
2022-03-22
Committee on Banking, Housing, and Urban Affairs. Hearings held.
USSB3799Intro
25%
Sets out programs and activities primarily to address public health preparedness and response. Specifically, the bill establishes a legislative task force to investigate the COVID-19 pandemic and a White House office to advise on pandemic preparednes...
[Detail][Text][Discuss]
2022-03-15
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
USHB3755Engross
50%
Prohibits governmental restrictions on the provision of, and access to, abortion services. Specifically, governments may not limit a provider's ability to prescribe certain drugs, offer abortion services via telemedicine, or immediately provide abort...
[Detail][Text][Discuss]
2022-02-28
Cloture on the motion to proceed to the measure not invoked in Senate by Yea-Nay Vote. 46 - 48. Record Vote Number: 65. (CR S826)
USSB3700Intro
25%
Limits cost-sharing for insulin under private health insurance and the Medicare prescription drug benefit. Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $35 or 25% of a pl...
[Detail][Text][Discuss]
2022-02-17
To Senate Finance Committee
USSB3629Intro
25%
Expands access to substance use disorder treatment by modifying the regulation of opioid treatment programs and narcotic drugs used for treatment, including with respect to a patient's unsupervised use of such drugs. Specifically, the Department of H...
[Detail][Text][Discuss]
2022-02-10
To Senate Health, Education, Labor, And Pensions Committee
USSB3593Intro
25%
Expands and otherwise modifies coverage of telehealth services under Medicare until two years after the end of the COVID-19 public health emergency. Specifically, the bill (1) allows federally qualified health centers and rural health clinics to serv...
[Detail][Text][Discuss]
2022-02-08
To Senate Finance Committee
USHB6000Intro
25%
Addresses pandemic preparedness and public health issues, caregiver and patient engagement, drug development, insurance coverage, and biomedical research. The Department of Health and Human Services (HHS) must undertake research and other activities ...
[Detail][Text][Discuss]
2022-01-04
To House Biotechnology, Horticulture, and Research Committee
USHB3537PassEstablishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions. The Department of Health and Human Services (HHS) shall award ...
[Detail][Text][Discuss]
2021-12-23
Became Public Law No: 117-79. (TXT | PDF)
USHB6279Intro
25%
Expands access to substance use disorder treatment by modifying the regulation of opioid treatment programs and narcotic drugs used for treatment, including with respect to a patient's unsupervised use of such drugs. Specifically, the Department of H...
[Detail][Text][Discuss]
2021-12-15
To House Subcommittee on Health
USHB2355Engross
50%
Modifies overdose prevention activities carried out by the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC). Specifically, HHS must update pharmacist training materials to include information abou...
[Detail][Text][Discuss]
2021-12-09
To Senate Health, Education, Labor, And Pensions Committee
USHB2364Engross
50%
Requires the Department of Health and Human Services (HHS) to provide education and training related to synthetic opioids, including fentanyl and its analogues. Specifically, HHS must launch a public education campaign on the dangers of synthetic opi...
[Detail][Text][Discuss]
2021-12-09
To Senate Health, Education, Labor, And Pensions Committee
USSB1428Intro
25%
Authorizes the Federal Trade Commission (FTC) to initiate proceedings against parties to any agreement resolving or settling a patent infringement claim in connection with the sale of a drug or biological product. Such an agreement is presumed to hav...
[Detail][Text][Discuss]
2021-12-09
Placed on Senate Legislative Calendar under General Orders. Calendar No. 180.
USSB1425Intro
25%
Makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug. The bill authorizes the Federal Tr...
[Detail][Text][Discuss]
2021-12-08
Placed on Senate Legislative Calendar under General Orders. Calendar No. 179.
USSB3291Intro
25%
Expands various initiatives to address antibiotic resistance. The bill reestablishes the interagency Antimicrobial Resistance Task Force to coordinate and develop efforts addressing antibiotic resistance. The Department of Health and Human Services m...
[Detail][Text][Discuss]
2021-12-01
To Senate Health, Education, Labor, And Pensions Committee
USHB5376Intro
25%
Provides funding, establishes programs, and otherwise modifies provisions relating to a broad array of areas, including education, labor, child care, health care, taxes, immigration, and the environment. (The bill is commonly referred to as the Build...
[Detail][Text][Discuss]
2021-11-19
Motion to reconsider laid on the table.
USHB3043Intro
25%
Requires the Department of Health and Human Services, in coordination with the Department of Justice, the Department of Labor, and relevant state agencies, to enter into an arrangement with the National Academy of Sciences in order to study the effec...
[Detail][Text][Discuss]
2021-11-09
To House Subcommittee on Crime, Terrorism, and Homeland Security
USHB2379Engross
50%
Reauthorizes through FY2027 and otherwise changes the State Opioid Response Grant program. This program, which is managed by the Substance Abuse and Mental Health Services Administration, provides funding for states, territories, and Indian tribes an...
[Detail][Text][Discuss]
2021-10-21
To Senate Health, Education, Labor, And Pensions Committee
USHB3635Engross
50%
Makes changes to the administration and management of the Strategic National Stockpile. Among these changes, the bill authorizes through September 30, 2024, the Department of Health and Human Services (HHS) to transfer supplies from the stockpile to ...
[Detail][Text][Discuss]
2021-10-21
To Senate Health, Education, Labor, And Pensions Committee
USHB4369Engross
50%
Directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education (or consortia of such institutions) as National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing and to provide grants...
[Detail][Text][Discuss]
2021-10-20
To Senate Health, Education, Labor, And Pensions Committee
USSB2910Intro
25%
A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period, and for other purposes.
[Detail][Text][Discuss]
2021-10-20
Star Print ordered on the bill.
USHB19Intro
25%
Establishes and modifies several programs and requirements to address prescription drug prices. The bill modifies provisions under Medicare and Medicaid relating to prescription drug coverage and price transparency. Among other changes, the bill requ...
[Detail][Text][Discuss]
2021-10-19
To House Subcommittee on Antitrust, Commercial, and Administrative Law
USHB2067Intro
25%
Requires health care providers, as a condition of receiving or renewing a registration to prescribe potentially addictive drugs, to complete a one-time training on managing patients with substance use disorders. In addition, the Department of Health ...
[Detail][Text][Discuss]
2021-10-19
To House Subcommittee on Crime, Terrorism, and Homeland Security
USHB2148Intro
25%
Establishes a series of oversight and disclosure requirements relating to the prices of brand-name drugs. Specifically, the bill requires the Department of Health and Human Services (HHS) to review at least annually all brand-name drugs for excessive...
[Detail][Text][Discuss]
2021-10-19
To House Subcommittee on Antitrust, Commercial, and Administrative Law
USHB2366Intro
25%
Addresses data collection, treatment, harm reduction, and other issues related to substance misuse and addiction. It particularly focuses on opioids, fentanyl, and related substances. Specifically, the bill expands surveillance of fentanyl and relate...
[Detail][Text][Discuss]
2021-10-19
To House Subcommittee on Crime, Terrorism, and Homeland Security
USHB4981PassExtends the deadline, from 270 days to 390 days, for the Commission on Combating Synthetic Opioid Trafficking to submit the final report on its activities and recommendations to combat the flow of synthetic opioids into the United States.
[Detail][Text][Discuss]
2021-10-19
Became Public Law No: 117-51. (TXT | PDF)
USSB2983Intro
25%
Authorizes the Food and Drug Administration (FDA) to create an expedited drug approval process specifically for drugs that are currently approved for sale in certain countries (i.e., a European Economic Area member country, Australia, Canada, Israel,...
[Detail][Text][Discuss]
2021-10-07
To Senate Health, Education, Labor, And Pensions Committee
USHB1456Intro
25%
Reauthorizes through FY2025 and modifies operations of the Peace Corps. Changes include expanding benefits and services for volunteers by increasing the readjustment allowance paid to volunteers when their service terminates and providing statutory a...
[Detail][Text][Discuss]
2021-09-30
Ordered to be Reported in the Nature of a Substitute (Amended) by Voice Vote.
USHB2884Intro
25%
Limits in certain instances the number of patents that the manufacturer of a biologic drug can assert in a lawsuit against a company seeking to sell a biosimilar version of that drug. (A biologic drug is produced through natural processes or isolated...
[Detail][Text][Discuss]
2021-09-30
Ordered to be Reported in the Nature of a Substitute by Voice Vote.
USHB2891Intro
25%
Authorizes the Federal Trade Commission (FTC) to initiate proceedings against parties to any agreement resolving or settling a patent infringement claim in connection with the sale of a drug or biological product. Such an agreement is presumed to hav...
[Detail][Text][Discuss]
2021-09-29
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 13.
USHB2883Intro
25%
Makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug. The bill authorizes the Federal Tr...
[Detail][Text][Discuss]
2021-09-29
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 31 - 9.
USHB2873Intro
25%
Prohibits product hopping by drug manufacturers and authorizes the Federal Trade Commission to sue in court or institute administrative proceedings to enforce this prohibition. Generally, product-hopping describes a situation where, when the patents ...
[Detail][Text][Discuss]
2021-09-29
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 27 - 16.
USHB5388Intro
25%
To establish a strategic active pharmaceutical ingredient reserve to maintain a domestic supply of active pharmaceutical ingredients and key starting materials needed for the manufacturing of essential generic medicines, and to build a pipeline for d...
[Detail][Text][Discuss]
2021-09-28
To House Subcommittee on Health
USHB5260Intro
25%
Establishes and alters several programs and requirements relating to the prices of prescription drugs. For example, the bill establishes and alters several requirements under Medicare and Medicaid, including requiring drug manufacturers to issue reba...
[Detail][Text][Discuss]
2021-09-15
To House Subcommittee on Health
USSB2740Intro
25%
A bill to establish a strategic active pharmaceutical ingredient reserve to maintain a domestic supply of active pharmaceutical ingredients and key starting materials needed for the manufacturing of essential generic medicines, and to build a pipelin...
[Detail][Text][Discuss]
2021-09-14
To Senate Health, Education, Labor, And Pensions Committee
USHB5237Intro
25%
Establishes and alters several programs and requirements relating to the prices of prescription drugs. For example, the bill establishes and alters several requirements under Medicare and Medicaid, including requiring drug manufacturers to issue reba...
[Detail][Text][Discuss]
2021-09-13
To House Subcommittee on Health
USHB5099Intro
25%
Transfers certain programs that provide Medicare premium and cost-sharing assistance for low-income individuals from Medicaid to Medicare. Specifically, the bill establishes a program under Medicare to assist low-income Medicare beneficiaries with pr...
[Detail][Text][Discuss]
2021-08-25
To House Subcommittee on Health
USSB2622Intro
25%
Provides for Medicaid and Children's Health Insurance Program (CHIP) coverage of certain tobacco cessation services. Specifically, the bill provides for coverage, without cost-sharing, of diagnostic, therapy, and counseling services and pharmacothera...
[Detail][Text][Discuss]
2021-08-05
To Senate Finance Committee
USSB2589Intro
25%
Directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education (or consortia of such institutions) as National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing and to provide grants...
[Detail][Text][Discuss]
2021-08-03
To Senate Health, Education, Labor, And Pensions Committee
Syndicate content
feedback